Specializing in dry eye diagnosis and management for over 30 years, I-MED Pharma provides ocular surface disease (OSD) solutions to Canadian ophthalmologists, optometrists, and the global eye care community. Our mission is to bring complete relief to dry eye and OSD patients worldwide. To do this, we continually research and develop the most effective and advanced solutions for dry eye disease. I-MED Pharma offers a complete range of ocular surface disorder products, including diagnostic tools, artificial tears, ocular hygiene cleansers, IRPL® treatment solutions, punctum plugs, nutritional supplements, and therapeutic accessories.

www.imedpharma.com

Health Care

Health Diagnostics

Medical Devices

Therapeutics

I-MED Pharma Inc.

Daniel H.

Cynthia Todd

Cosmin Vasiu

Nancy Erickson

Laura Baldassare

Paul Donnelly

Ilan Hofmann

The Leadership Team at I-MED Pharma Inc. spearheads the strategic direction and decision-making process for the company. Comprised of the Chief Executive Officer, Principal R&D Scientist, and Chief Scientific Officer, this team ensures the alignment of research and development with the corporate mission, driving innovation in dry eye and ocular surface disease solutions. They are responsible for overseeing product development, scientific advancements, and overall company growth to bring effective relief to patients worldwide.

Leadership Team

Marketing and Business Development

Regional Management

Leadership Team

About

Team members

Other teams at I-MED Pharma Inc.

Marketing and Business Development

Regional Management